TY - JOUR
T1 - Continuous infusion of β-amyloid protein into the rat cerebral ventricle induces learning impairment and neuronal and morphological degeneration
AU - Nitta, Atsumi
AU - Fukuta, Taneo
AU - Hasegawa, Takaaki
AU - Nabeshima, Toshitaka
PY - 1997
Y1 - 1997
N2 - To investigate the toxicity of β-amyloid protein, a component of the senile plaques in Alzheimer's disease, it was infused into the cerebral ventricle of rats for 14 days by a mini-osmotic pump. Performances in the water maze and passive avoidance tasks in β-amyloid protein-treated rats were impaired. Choline acetyltransferase activity significantly decreased in the hippocampus both immediately and 2 weeks after the cessation of the infusion. However, the learning impairment was recoverable 2 weeks after cessation of the infusion. Both immediately and 2 weeks after the cessation of the infusion, glial fibrillary acidic protein immunoreactivity increased. Furthermore, β-amyloid protein altered the staining in the nuclei of hippocampal cells for only 2 weeks after the cessation. These results suggest that β-amyloid protein produces some damage in the central nervous system in vivo.
AB - To investigate the toxicity of β-amyloid protein, a component of the senile plaques in Alzheimer's disease, it was infused into the cerebral ventricle of rats for 14 days by a mini-osmotic pump. Performances in the water maze and passive avoidance tasks in β-amyloid protein-treated rats were impaired. Choline acetyltransferase activity significantly decreased in the hippocampus both immediately and 2 weeks after the cessation of the infusion. However, the learning impairment was recoverable 2 weeks after cessation of the infusion. Both immediately and 2 weeks after the cessation of the infusion, glial fibrillary acidic protein immunoreactivity increased. Furthermore, β-amyloid protein altered the staining in the nuclei of hippocampal cells for only 2 weeks after the cessation. These results suggest that β-amyloid protein produces some damage in the central nervous system in vivo.
UR - http://www.scopus.com/inward/record.url?scp=0031051960&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031051960&partnerID=8YFLogxK
U2 - 10.1254/jjp.73.51
DO - 10.1254/jjp.73.51
M3 - Article
C2 - 9032134
AN - SCOPUS:0031051960
SN - 0021-5198
VL - 73
SP - 51
EP - 57
JO - Japanese Journal of Pharmacology
JF - Japanese Journal of Pharmacology
IS - 1
ER -